GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 147, Issue 3, Pages 577-585
Publisher
Springer Science and Business Media LLC
Online
2020-05-19
DOI
10.1007/s11060-020-03470-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune check-point in glioblastoma multiforme
- (2019) F. De Felice et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The current state of immunotherapy for gliomas: an eye toward the future
- (2019) Peter E. Fecci et al. JOURNAL OF NEUROSURGERY
- Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
- (2018) Taiji Iwasawa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Concepts for Immunotherapies in Gliomas
- (2018) Michael Platten et al. SEMINARS IN NEUROLOGY
- Immunotherapy with anti-GD2 antibody ch14.18/CHO±IL2 within the HR-NBL1/SIOPEN trial to improve outcome of high-risk neuroblastoma patients compared to historical controls.
- (2018) Ruth Lydia Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
- (2018) Giulia Golinelli et al. CANCER GENE THERAPY
- Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
- (2018) Ruth Ladenstein et al. LANCET ONCOLOGY
- Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
- (2016) Julien Fleurence et al. Oncotarget
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
- (2015) Azeem A. Rehman et al. Neurosurgical Focus
- Vaccine therapies for patients with glioblastoma
- (2014) Eli T. Sayegh et al. JOURNAL OF NEURO-ONCOLOGY
- Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD2 Antibody
- (2014) Nikolai Siebert et al. PLoS One
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More